Amy Mcbride Wendell has bought stock on 5 days since Mar 2018
Director at Axogen, Inc., and 2 other companies
SEC CIK 0001400568 · Filings on SEC.gov ↗
Amy Mcbride Wendell's record
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Companies
Every filing
8 filings since Mar 2018, newest first
Axogen, Inc.
Director
Axogen, Inc.
Director
Solventum Corp
Director
Axogen, Inc.
Director
Axogen, Inc.
Director
Axogen, Inc.
Director
Axogen, Inc.
Director
Hologic Inc
Director
About Amy Mcbride Wendell
Amy McBride Wendell is a corporate director serving on the boards of Axogen, Inc. (AXGN) and Hologic, Inc. (HOLX).( As a Director at Axogen, a company focused on nerve repair products, she has engaged in multiple stock transactions, including selling 5,000 shares on March 3, 2025, for $100,100 at a weighted average price of $20.02 per share, leaving her with 97,899 shares directly owned,( and selling 20,436 shares on December 16, 2025, for approximately $599,020, retaining 112,074 shares afterward.(
She received an annual equity grant of 14,150 restricted stock units (RSUs) valued at $150,000 on June 19, 2025, vesting on the one-year anniversary.( Across her tenure at Axogen, she has sold a total of 43,684 shares for about $1,280,465, with no reported purchases.( At Hologic, she owns approximately 10,297 shares valued over $771,348.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.